The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment
M
The Medicines Patent Pool today announced that it has signed a licence w
8th Invitation for Expression of Interest (EOI) to manufacturers of Reproductive Health products
M
The following products were added:
Treatment of maternal syphilis and prevention of congenital syphilis
Adult formulations
Newly Prequalified Active Pharmaceutical Ingredient (API)
M
Medroxyprogesterone manufactured by Taizhou Taifa Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
Newly prequalified Quality Control Laboratory (QCL)
M
New addition to the List of Prequalified Quality Control Laboratories (QCL):
8 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list